EP2376915
Aðferð til að sjúkdómsgreina MPS III-röskun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
31.12.2009EP published:
29.3.2017EP application number:
09837207.1
EP translation filed:
21.4.2017Grant published:
15.5.2017EPO information:
European Patent Register
Max expiry date:
30.12.2029Expiry date:
30.12.2026Next due date:
31.12.2026
Title:
METHOD FOR DIAGNOSING MPS IIIB DISORDER
Timeline
Today
31.12.2009EP application
29.3.2017EP Publication
21.4.2017Translation submitted
15.5.2017Registration published
30.12.2026Expires
Owner
Name:
BioMarin Pharmaceutical Inc.Address:
105 Digital Drive, 94949, Novato, CA, US
Inventor
Name:
CRAWFORD, Brett E.Address:
PowayCalifornia, US
Name:
BROWN, Jillian R.Address:
PowayCalifornia, US
Name:
GLASS, Charles A.Address:
San DiegoCalifornia, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
142291 PDate:
2.1.2009Country:
US
Number:
164365 PDate:
27.3.2009Country:
US
Number:
649094Date:
29.12.2009Country:
US
Classification
Categories:
G01N 33/50, G01N 33/66
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 1.12.2017
Expires: 30.12.2018
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 3.12.2018
Expires: 30.12.2019
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 5.12.2019
Expires: 30.12.2020
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 1.12.2020
Expires: 30.12.2021
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 1.12.2021
Expires: 30.12.2022
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 22.11.2022
Expires: 30.12.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 12.12.2023
Expires: 30.12.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 28.11.2024
Expires: 30.12.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 19.12.2025
Expires: 30.12.2026
Payer: Árnason Faktor ehf.